Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 25 Sept 2024 for Nautilus Biotechnology, Inc., €19k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Mary E. Godwin: trading record in brief
This profile gathers the share dealings of Mary E. Godwin in Nautilus Biotechnology, Inc. The record holds 2 filings, for trades running from 17 September 2024 to 23 September 2024.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 25 September 2024 with an option exercise (€19k) in Nautilus Biotechnology, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mary E. Godwin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
47,031 shares@ US$0.4657.4% of flowCommon StockSEC:0001808805-24-000067:0
35,000 shares@ US$0.4642.6% of flowCommon StockSEC:0001808805-24-000065:0
2 of 2 declarations
